# Pressure Wire Guided Cardiac Resynchronisation Therapy

Study · id `cardio:ct-nct01464502` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01464502](<https://clinicaltrials.gov/study/NCT01464502>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01464502

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 282 participants.

## Technical summary

Registry record NCT01464502. Randomized; no masking; primary purpose treatment. Start 2012-09 (registry gives no type); primary completion 2018-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 282 participants (planned count; ClinicalTrials.gov record NCT01464502, source copy `cardio:ctgov-nct01464502-2017-04-04`, retrieved 2026-10-26)
- Start date: 2012-09 (registry gives no type) (ClinicalTrials.gov record NCT01464502, source copy `cardio:ctgov-nct01464502-2017-04-04`, retrieved 2026-10-26)
- Primary completion: 2018-04 (anticipated) (ClinicalTrials.gov record NCT01464502, source copy `cardio:ctgov-nct01464502-2017-04-04`, retrieved 2026-10-26)
- Completion: 2018-04 (anticipated) (ClinicalTrials.gov record NCT01464502, source copy `cardio:ctgov-nct01464502-2017-04-04`, retrieved 2026-10-26)
- Countries: Italy; United Kingdom (ClinicalTrials.gov record NCT01464502, source copy `cardio:ctgov-nct01464502-2017-04-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01464502-2017-04-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pressure Wire Guided Cardiac Resynchronisation Therapy
- Condition: Heart Failure
- Intervention (Procedure): Standard CRT Implant
- Intervention (Procedure): Pressure-wire guided CRT implant
- Lead sponsor: Guy's and St Thomas' NHS Foundation Trust
- Lead sponsor class: OTHER
- Collaborator: Abbott Medical Devices
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Guy's and St Thomas' NHS Foundation Trust (`cardio:org-guy-s-and-st-thomas-nhs-foundation-trust`)
- Registry lists this organization as a collaborator: Abbott (`cardio:abbott`)

## Provenance

Content hash: b7b0173f0855ec385adad994f190a0535074d603fba88dade9c035a8c6ab181c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
